Voleon Capital Management LP Biogen Inc. Transaction History

Voleon Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $15.7 Million - $17.6 Million	-72,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $15.8 Million - $17.4 Million	72,000 New	72,000 $16.8 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $16.7 Million - $26.1 Million	-77,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $21.4 Million - $27.2 Million	77,000 New	77,000 $23.2 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Voleon Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Voleon Capital Management LP with notifications on news.